Insight

Elvina Almuradova: Could BC Treatments Impact Alzheimer’s Risk?

Elvina Almuradova/X

Jun 30, 2025, 05:12

Elvina Almuradova: Could BC Treatments Impact Alzheimer’s Risk?

Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared on X about a recent paper shared by Su-Min Jeong et al. published in JAMA Network:

“Could BC treatments impact Alzheimer’s risk?

A Korean cohort study of breast cancer survivors found that they had an 8% lower risk of developing Alzheimer’s disease compared with age-matched cancer-free women (SHR: 0.92).”

Title: Alzheimer Disease in Breast Cancer Survivors

Authors: Su-Min Jeong, Wonyoung Jung, Hyeonjin Cho, Hea Lim Choi, Keun Hye Jeon, Ki-Woong Nam, Yun-Gyoo Lee, Bongseong Kim, Kyungdo Han, Dong Wook Shin

Read Full Article.

Read an insight: “Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More”

Alzheimer’s disease Bongseong Kim Breast Cancer cancer cancer survivors Dong Wook Shin Elvina Almuradova Hea Lim Choi Hyeonjin Cho Keun Hye Jeon Ki-Woong Nam Kyungdo Han OncoDaily Oncology Su-Min Jeong Wonyoung Jung Yun-Gyoo Lee

Garo Armen Shares a Personal Story Driving Agenus' Mission in Cancer Care

Dr. Oliver Bogler, PhD: Leaving the National Cancer Institute

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care

Sibylle Loibl: Final survival Results from the PENELOPE-B trial published in Annals of Oncology

Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night